Moderna Signs Single Drug Deal With CF Expert Vertex For Up To $315m

Moderna Therapeutics LLC extended its dealmaking streak and signaled a shift for its collaborative strategy by signing a partnership with Vertex Pharmaceuticals Inc. to develop a cystic fibrosis (CF) therapy based on the private biotechnology firm's messenger RNA (mRNA)-based drug development technology.

chemistry

Moderna Therapeutics LLC extended its dealmaking streak and signaled a shift for its collaborative strategy by signing a partnership with Vertex Pharmaceuticals Inc. to develop a cystic fibrosis (CF) therapy based on the private biotechnology firm's messenger RNA (mRNA)-based drug development technology.

The agreement with Vertex, a dominant player in the field of novel CF therapeutics, gives Cambridge, Massachusetts-based Moderna $40m up...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip